258 related articles for article (PubMed ID: 10561675)
1. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
Reisman H; Martin D; Gast MJ
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
Archer DF; Maheux R; DelConte A; O'Brien FB
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
[TBL] [Abstract][Full Text] [Related]
3. Alesse: leading the shift to 20 microg.
Archer DF
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):37-8. PubMed ID: 10561673
[No Abstract] [Full Text] [Related]
4. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
Young RL; DelConte A
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):59-62. PubMed ID: 10561677
[TBL] [Abstract][Full Text] [Related]
5. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
6. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
Chavez A; DelConte A
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):75-83. PubMed ID: 10427482
[TBL] [Abstract][Full Text] [Related]
7. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol.
Coney P; DelConte A
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):53-8. PubMed ID: 10561676
[TBL] [Abstract][Full Text] [Related]
8. The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
Archer DF; Mammen EF; Grubb GS
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):63-6. PubMed ID: 10561678
[TBL] [Abstract][Full Text] [Related]
9. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Edelman AB; Koontz SL; Nichols MD; Jensen JT
Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
Endrikat J; Hite R; Bannemerschult R; Gerlinger C; Schmidt W
Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
Bannemerschult R; Hanker JP; Wünsch C; Fox P; Albring M; Brill K
Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.
Bjarnadóttir RI; Tuppurainen M; Killick SR
Am J Obstet Gynecol; 2002 Mar; 186(3):389-95. PubMed ID: 11904596
[TBL] [Abstract][Full Text] [Related]
13. Biphasic versus triphasic oral contraceptives for contraception.
van Vliet HA; Grimes DA; Helmerhorst FM; Schulz KF
Contraception; 2002 May; 65(5):321-4. PubMed ID: 12057781
[TBL] [Abstract][Full Text] [Related]
14. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
[TBL] [Abstract][Full Text] [Related]
16. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
18. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
Masson S; Franssen E; Hilditch JR; Powell MG
Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
[TBL] [Abstract][Full Text] [Related]
19. Using a low-dose contraceptive in women 35 years of age and over: 20 microg estradiol/100 microg levonorgestrel.
Carr BR; DelConte A
Contraception; 2002 Jun; 65(6):397-402. PubMed ID: 12127636
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
Kaunitz AM
Contraception; 2000 May; 61(5):295-302. PubMed ID: 10906499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
